In a world first, a bespoke gene-editing therapy benefitted one child. Now reseachers plan to launch a clinical trial of the ...

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

A U.S. regulator reportedly plans to unveil a faster approach to approving custom gene-editing treatments for rare diseases.

A top US regulator plans to unveil a faster approach to approving custom gene-editing treatments, a move designed to unleash a wave of industry investment that will yield cures for patients with rare ...

Some of the most expensive drugs currently in use are gene therapies to treat specific diseases, and their high cost limits ...